Expanded use of Xolair to treat food allergies approved by the FDA
Feb 17, 2024
Xolair is not meant to substitute for emergency anaphylaxis medications such as the EpiPen.
Salt substitute can reduce incidence of hypertension among seniors
Feb 12, 2024
No increase was seen in the incidence of hypotension episodes with replacement of salt by a potassium-enriched substitute.
Environmental Protection Agency finalizes stronger air quality standards
Feb 09, 2024
The agency estimates that the new standard will prevent up to 4,500 premature deaths in the first year of full enforcement.
IV Ketamine not a ‘silver bullet’ for depression, but does help some
Feb 09, 2024
One-fourth with treatment-resistant depression show a response at six weeks.
ASA: Nearly one in five people develop dementia after stroke
Feb 08, 2024
In the first year after stroke, there is an almost threefold higher risk for dementia.
Reduced cancer risk seen after 10 years since quitting smoking
Feb 08, 2024
After 15 or more years since quitting, the cancer risk reached 50% of that associated with continued smoking.
Diabetic retinopathy tied to lower vision-related quality of life
Feb 06, 2024
Greater declines in quality of life were seen for higher-severity diabetic retinopathy.
Radon exposure linked to increased risk for stroke in women
Feb 01, 2024
Stroke risk was significantly elevated at concentrations ranging from 2 to 4 pCi/L, below the US EPA Radon Action Level.
Cardio, cardio + resistance training improve CVD risk profile at one year
Jan 31, 2024
No similar benefit was seen for resistance exercise alone in adults with overweight or obesity, however.
Philips suspends US sales of CPAP, ventilator machines after recall
Jan 29, 2024
Following a recall of millions of its breathing machines that began in mid-2021, Philips Respironics announced Monday that it would halt sales of all such machines within the United States.